Zobrazeno 1 - 7
of 7
pro vyhledávání: '"NT Siordiya"'
Autor:
Elza Lomaia, E.V. Sokurova, M.A. Mikhalev, M.G. Pozina, Olga Senderova, A.S. Khazieva, A.Yu. Zaritskey, E.B. Zhalsanova, V.V. Ust’yantseva, O.E. Ochirova, Yu.D. Rogovaya, G.P. Dimov, K.B. Trizna, A.Yu. Furtovskaya, A.A. Otmorskaya, O.Yu. Li, NT Siordiya
Publikováno v:
Clinical oncohematology. 13:335-345
Aim. To assess the efficacy of targeted therapy with ruxolitinib in patients with myelofibrosis in real clinical practice in Russia. To determine the prognostic value of spleen reduction in the early stages of ruxolitinib treatment and its effect on
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 12, Iss 3, Pp 297-302 (2019)
Aim. To assess the rate of WT1 gene overexpression and its clinical value in Ph-negative myeloproliferative disorders (MPD). Materials & Methods. The trial included 72 patents with Ph-negative MPD. Among them there were patients with primary myelofib
Autor:
Pavel Butylin, VI Khvan, EG Lisina, NT Siordiya, SN Leleko, OV Sirotkina, AA Silyutina, NM Matyukhina
Publikováno v:
Kliničeskaâ onkogematologiâ, Vol 10, Iss 4, Pp 479-484 (2017)
Background. The study of pro- and antifibrotic factors in the serum of patients with Ph-negative chronic myeloproliferative disorders (CMPDs) will allow to understand better the mechanisms of myelofibrosis development, as well as to identify new diag
Autor:
Andrey Sudarikov, Elza Lomaia, E A Gilyazitdinova, Elena K. Egorova, EI Pustovaya, T I Koloshejnova, Valery G. Savchenko, I N Subortseva, Alla M. Kovrigina, A O Abdullaev, A L Melikyan, NT Siordiya, A.Yu. Zaritskey
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 23-29 (2018)
Purpose of the study. A comparative evaluation of the effectiveness of different therapeutic strategies in patients with polycythemia vera (PV) and essential thrombocythemia (ET). Materials and methods. Patients with PV or ET, diagnosed according to
Autor:
Tamara Chitanava, Agniia-Polina Poshivay, Andrey Zaritskey, Vasily Shuvaev, Nadezhda Shnalieva, Darina Zammoeva, Mikhail Fominykh, Irina Martynkevich, Natalia Polezhajkovskaya, NT Siordiya, Eugenia Sbityakova, Anna Kersilova, Elena Koryagina, Nadezhda Medvedeva, Elena Tochenaya, Svetlana Stepanova, Natalia Ilyina, Elza Lomaia, Natalia Lazorko, Elizaveta Efremova, Olga Merzlikina, Anna Klimovich, Tatiana Shneider, Natalia Dorofeeva
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:S242
Context Tyrosine kinase inhibitors in third-line therapy (TKI-3L) in chronic-phase chronic myelogenous leukemia (CP CML) is effective in a portion of patients. Meanwhile, it is unclear which patients may benefit from TKI-3L. Objective To identify the
Autor:
Pavel Butylin, Marina Konopleva, Natalia Matuhina, Andrey Zaritskiy, NT Siordiya, Konstantin Bogdanov, Anna Silutina, Elza Lomaia, Ekaterina Lisina
Publikováno v:
Blood. 128:5498-5498
Background. Wt1 expression is thoroughly studied in acute myeloblastic leukemia and widely used for disease response monitoring.Its role in MPN is less known. Aim. The aim of the study was to reveal the incidence of elevated Wt1 expression in PMF and
Autor:
Melikyan AL; National Research Center for hematology, Moscow, Russia., Subortseva IN; National Research Center for hematology, Moscow, Russia., Gilyazitdinova EA; National Research Center for hematology, Moscow, Russia., Koloshejnova TI; National Research Center for hematology, Moscow, Russia., Pustovaya EI; National Research Center for hematology, Moscow, Russia., Egorova EK; National Research Center for hematology, Moscow, Russia., Kovrigina AM; National Research Center for hematology, Moscow, Russia., Sudarikov AB; National Research Center for hematology, Moscow, Russia., Abdullaev AO; National Research Center for hematology, Moscow, Russia., Lomaia EG; Almazov National Medical Research Center, Saint Petersburg, Russia., Siordiya NT; Almazov National Medical Research Center, Saint Petersburg, Russia., Zaritskey AY; Almazov National Medical Research Center, Saint Petersburg, Russia., Savchenko VG; National Research Center for hematology, Moscow, Russia.
Publikováno v:
Terapevticheskii arkhiv [Ter Arkh] 2018 Aug 17; Vol. 90 (7), pp. 23-29.